Press release
Granulocyte Macrophage Colony Stimulating Factor Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2029
Other major factors attributable to the market growth includes the increasing prevalence of fungal infections, the rising prevalence of cancer, and the growing cases of failed skin grafting. Apart from COVID-19, the growing cancer cases substantially impact the market growth. North America region is likely to witness a significant growth in the market owing to the rising prevalence of cancer. This influences the market growth in the North American region. On the other side, the exorbitantly high cost of chemotherapy treatments, and side effects associated with the drug may restrain the growth of the global granulocyte macrophage colony stimulating factor market.
To Request a Sample of our Report on Granulocyte Macrophage Colony Stimulating Factor Market: https://www.omrglobal.com/request-sample/granulocyte-macrophage-colony-stimulating-factor-market
Market Coverage
The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030
Segment Covered-
By Route of Administration
By Application
By End-User
Regions covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape: Amgen Inc., Merck KGaA, and Sanofi S.A., among others.
Granulocyte Macrophage Colony Stimulating Factor Market Report by Segment
By Route of Administration
Subcutaneous Bolus
Intravenous Infusion
By Application
Fungal Infections
Skin Graft
Cut-Burn Wounds
Acute Myelogenous Leukemia
Others
By End-User
Hospitals and Clinics
Surgical Centers
Diagnostic Centers
Research Centers
Others
A full Report of Granulocyte Macrophage Colony Stimulating Factor Market is Available @ https://www.omrglobal.com/industry-reports/granulocyte-macrophage-colony-stimulating-factor-market
Granulocyte Macrophage Colony Stimulating Factor Market Report by Region
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of the World
Latin America
Middle East & Africa
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Granulocyte Macrophage Colony Stimulating Factor Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2029 here
News-ID: 3286511 • Views: …
More Releases from Orion Market Research
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Granulocyte
Pegylated Recombinant Human Granulocyte Colony Stimulating Factor Market Size An …
"The market for Pegylated Recombinant Human Granulocyte Colony Stimulating Factor (G-CSF) is projected to reach approximately USD 4.1 billion in 2024, driven by increasing incidences of hematological malignancies and the rising demand for effective supportive care in cancer treatment. The market is expected to expand at a robust Compound Annual Growth Rate (CAGR) of 8.5% from 2025 to 2034, potentially reaching around USD 9 billion by the end of this…
G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2024: Strategies An …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
The Business Research Company offers in-depth market insights through G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The g-csf (granulocyte colony stimulating factors) market size has…
G-CSF (Granulocyte Colony Stimulating Factors) Market Analysis, Trends, Growth, …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2023 identifies increasing demand for prophylaxis granulocyte colony-stimulating factor as the major driver for the G-CSF market's growth in the forecast period. The prophylaxis with G-CSF decreases the occurrence of febrile neutropenia (FN), allowing…
Granulocyte Macrophage Colony Stimulating Factor Market Value Projected to Expan …
Granulocyte macrophage colony stimulating factor market is anticipated to grow at a significant CAGR during the forecast period. Granulocyte macrophage colony-stimulating factor, also called as CSF2 (colony stimulating factor 2), is a monomeric glycoprotein released by usual killer cells, T cells, mast cells, macrophages, fibroblasts, and endothelial cells that acts as a cytokine. The COVID-19 pandemic has significantly affected the global granulocyte macrophage colony stimulating factor market. Since this factor…
Rising Demand for Granulocyte Macrophage Colony Stimulating Factor Market Key Pl …
The global granulocyte macrophage colony stimulating factor market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Granulocyte macrophage colony-stimulating factor, also called as CSF2 (colony stimulating factor 2), is a monomeric glycoprotein released by usual killer cells, T cells, mast cells, macrophages, fibroblasts, and endothelial cells that acts as a cytokine. The COVID-19 pandemic has significantly affected the global granulocyte macrophage colony stimulating factor market.…
Granulocyte-Colony Stimulating Factor Category to Dominate the Oncology Biosimil …
The demand for oncology biosimilar drugs has augmented in recent years. This is attributed to the rising prevalence of various types of cancers across the world. In addition, existing anti-cancer drugs in the pipeline are quite expensive, thus rendering them unaffordable to people in lower and middle income countries. As a consequence, the market for biosimilars has burgeoned.
For detailed insights on enhancing your product footprint, request for a sample…
